Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lexagene Holdings Inc LXXGQ

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.


GREY:LXXGQ - Post by User

Post by stockfyon Mar 03, 2021 11:11am
95 Views
Post# 32704737

Other Healthcare Stocks for Diversification

Other Healthcare Stocks for Diversification
Some other healthcare stocks if you want to diversify your holdings and reduce your portfolio risk.

See debt-free Cipher Pharmaceuticals (CPH), which has a lot of expertise in many dermatological products.
 
For instance, CPH produces excellent creams for acne (i.e. its well-known Epuris has 41% market share in Canada).
 
CPH is profitable and dirt-cheap trading just 1.4 times its EBITDA.
 
And CPH has many growth drivers in 2021 because it has many promising drugs in the pipeline with very positive clinical trials to-date. Just my two cents.


 
<< Previous
Bullboard Posts
Next >>